Hunan Warrant Pharmaceutical Co.,Ltd (SHA:688799)

SHA:688799 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	188.26	203.78	177.74	379.65	191.29	353.39
Short-Term Investments	-	50	296.78	349.66	181.66	-
Trading Asset Securities	20	10	183	15	325	400
Cash & Short-Term Investments	208.26	263.78	657.52	744.31	697.95	753.39
Cash Growth	-31.61%	-59.88%	-11.66%	6.64%	-7.36%	853.42%
Accounts Receivable	236.12	279.1	226.19	183.54	180.54	129.2
Other Receivables	3.55	3.21	16.5	2.14	2.19	1.49
Receivables	239.68	282.31	242.69	185.68	182.73	130.68
Inventory	390.97	392.46	412.43	362.67	339.26	300.53
Prepaid Expenses	-	3.13	2.48	1.11	1.83	2.49
Other Current Assets	267.78	234.54	118.15	55.98	26.57	18.89
Total Current Assets	1,107	1,176	1,433	1,350	1,248	1,206
Property, Plant & Equipment	1,177	1,003	687	596.78	563.76	472.98
Long-Term Investments	641.69	542.19	43.49	47.15	36.05	34.11
Goodwill	-	-	32.38	32.38	32.38	-
Other Intangible Assets	167.18	168.59	186.09	76.62	81.06	57.56
Long-Term Deferred Tax Assets	37.48	40.45	39.81	18.73	14.2	12.29
Long-Term Deferred Charges	40.41	10.99	10.44	5.32	3.26	0.23
Other Long-Term Assets	70.22	112.52	27.14	50.21	29.92	14.38
Total Assets	3,240	3,054	2,460	2,177	2,009	1,798

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	162.12	181.53	139.92	89.5	71.13	80.9
Accrued Expenses	14.53	37.06	24.51	26.04	20.61	72.81
Short-Term Debt	-	-	3.77	-	-	-
Current Portion of Long-Term Debt	0.52	0.37	0.05	0.01	-	-
Current Income Taxes Payable	3.87	4.38	13.32	9.97	1.29	0.94
Current Unearned Revenue	78.66	72.48	88.99	80.13	82.41	62.75
Other Current Liabilities	131.47	114.88	148.46	130.73	119.4	42.19
Total Current Liabilities	391.17	410.7	419.02	336.38	294.83	259.59
Long-Term Debt	672	497.6	113.93	17.11	-	-
Long-Term Unearned Revenue	101.17	102.65	98.8	49.94	53.19	56.92
Long-Term Deferred Tax Liabilities	-	-	0.02	-	2.33	0.01
Other Long-Term Liabilities	-	-	5.28	5.28	-	1.55
Total Liabilities	1,164	1,011	637.06	408.7	350.35	318.07

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	131.32	131.32	93.8	93.8	93.8	93.8
Additional Paid-In Capital	876.37	870.1	850.34	850.34	850.34	850.34
Retained Earnings	1,068	1,041	859.27	779.37	652.47	535.33
Total Common Equity	2,076	2,043	1,803	1,724	1,597	1,479
Minority Interest	-	-	19.17	44.73	62.01	-
Shareholders' Equity	2,076	2,043	1,823	1,768	1,659	1,479
Total Liabilities & Equity	3,240	3,054	2,460	2,177	2,009	1,798

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	672.52	497.98	117.75	17.12	-	-
Net Cash (Debt)	-464.26	-234.2	539.77	727.19	697.95	753.39
Net Cash Growth	-	-	-25.77%	4.19%	-7.36%	853.42%
Net Cash Per Share	-3.44	-1.74	4.11	5.53	5.32	6.73
Filing Date Shares Outstanding	131.32	131.32	131.32	131.32	131.32	131.32
Total Common Shares Outstanding	131.32	131.32	131.32	131.32	131.32	131.32
Working Capital	715.52	765.52	1,014	1,013	953.5	946.38
Book Value Per Share	15.81	15.56	13.73	13.12	12.16	11.27
Tangible Book Value	1,909	1,874	1,585	1,615	1,483	1,422
Tangible Book Value Per Share	14.53	14.27	12.07	12.29	11.29	10.83
Buildings	-	467.65	316.97	325.35	313.1	304.86
Machinery	-	581.56	539.11	491.33	372.49	274.63
Construction In Progress	-	323.73	143.06	27.62	70.5	43.05

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 28, 2026

Data Sources Report a data error